✦ LIBER ✦

Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: A double-blind placebo-controlled trial

✍ Scribed by Jonathan R.T. Davidson; Hans-Ulrich Wittchen; Pierre-Michel Llorca; Janelle Erickson; Michael Detke; Susan G. Ball; James M. Russell

Book ID: 118436927
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 544 KB
Volume: 18
Category: Article
ISSN: 0924-977X
DOI: 10.1016/j.euroneuro.2008.05.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of generalized anxiety disorde

Treatment of generalized anxiety disorder with escitalopram: Pooled results from double-blind, placebo-controlled trials

✍ Wayne K. Goodman; Anjana Bose; Qin Wang 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Deramciclane in the treatment of general

Deramciclane in the treatment of generalized anxiety disorder: A placebo-controlled, double-blind, dose-finding study

✍ Hannu Naukkarinen; Roope Raassina; Jukka Penttinen; Antti Ahokas; Riitta Jokinen 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder

✍ Y. Lecrubier; A. J. Puech; A. Azcona; P. E. Bailey; X. Lataste 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 594 KB

Predictors of relapse in a study of dulo

Predictors of relapse in a study of duloxetine treatment for patients with generalized anxiety disorder

✍ J. Alexander Bodkin; Christer Allgulander; Pierre M. Llorca; Melissa E. Spann; D 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

## Objective Data from a relapse prevention study of duloxetine treatment for adults with generalized anxiety disorder (GAD) were examined to identify predictors of relapse. ## Methods Patients responding to 6 months of open‐label duloxetine treatment were randomized to continuation with duloxeti

Switching from long-term benzodiazepine

Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial

✍ Hadley, S. J.; Mandel, F. S.; Schweizer, E. 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 343 KB

Efficacy and tolerability of duloxetine

Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies

✍ Jonathan Davidson; Christer Allgulander; Mark H. Pollack; James Hartford; Janell 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Abstract ## Objective To assess the efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder (GAD). ## Methods Acute‐phase data from a subset of patients (≥65 years) with GAD were pooled from four randomized, double‐blind, placebo‐controlled trials of dulo